PENSA PHARMA RENEWS ITS CORPORATE WEBSITE AND LAUNCHES LOCAL WEBSITES
www.pensapharma.com is the corporate website of the generic drug activity of the ESTEVE chemical-pharmaceutical group
The company has also created specific portals for some of the countries where it currently operates, such as Spain, Italy and Portugal
The multi-device design of all these sites allows users to access the information in the format that best fits their needs and preferences
Pensa Pharma (PENSA), a company of the ESTEVE group specializing in generic drugs, has just renewed its www.pensapharma.com website with new contents, a modern image and an optimized structure adapted to any device. PENSA has also launched specific portals for some of the countries where it currently operates, namely Spain, Italy and Portugal.
The main purpose of renewing the corporate portal and launching the different local websites is to structure the information in a way that reflects the international nature of PENSA and maximally potentiates the experience of any user accessing the information about the company and its activities, products or services, as well as to standardize its image in the different countries where it currently operates.
The renewed www.pensapharma.com website of generic drug activities is offered in two languages (Spanish and English) and gathers the values and characteristics of the company as well as information on its capacity to develop, manufacture and market generic drugs of high added value. PENSA has also created specific websites for some of the countries where it currently operates, namely Spain (www.pensapharma.es), Italy (www.pensapharma.it) and Portugal (www.pensapharma.pt), each with its own visual personality, area-specific information, vade mecum and services valuable to the pharmacist.
In this sense, the www.pensandoentufarmacia.com portal, created scarcely a year ago, outstands for contents specifically devised for the pharmacist and the pharmacy about human resources, sports, nutrition, ideas to create effective and eye-catching showcases, and health tips available in factsheet format that can be downloaded and shared with patients and users.
THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’
Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...read more
PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES
Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...read more
ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER
ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...read more